ArticleDiabetes care2026
Midchildhood Obesity After Exposure to Gestational Diabetes Mellitus: The SWIFT Study in Youth.
Article in Diabetes care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo assess how treatment type, diagnosis timing, and meeting of glycemic targets in gestational diabetes mellitus (GDM) affect childhood obesity risk. RESEARCH DESIGN AND
methodsThis study included 809 mothers with GDM, treated with diet or glyburide, who enrolled at 6-9 weeks postdelivery in a prospective cohort (2008-2011) and their children who had a BMI measurement between ages 5 and 11 years, after exclusion of mothers with diabetes diagnosis postdelivery. Mothers' GDM diagnosis timing (early [<24 weeks gestation] vs. standard [≥24 weeks]), treatment type, and meeting of self-monitored glycemic targets, along with children's weight and height at ages 5-11 years, were obtained from Kaiser Permanente Northern California electronic health records. Log-binomial regression models estimated adjusted relative risks (aRRs) and 95% CIs of childhood obesity, adjusting for covariates including glycemic targets and maternal prepregnancy BMI.
resultsParticipants were multiethnic (77% Asian, Black, or Hispanic), with a mean (SD) prepregnancy BMI of 29.4 (7.2) kg/m2. GDM was diagnosed early (<24 weeks) in 20%, glyburide treatment was provided to 27%, and glycemic targets were met by 70% of participants. Child BMI percentiles were obtained at a mean (SD) age of 9.5 (1.5) years (58% normal weight, 17% overweight, and 25% obesity). In a joint analysis of GDM treatment type and diagnosis timing, compared with standard diagnosis and dietary treatment (referent), the aRR (95% CI) of childhood obesity was 1.58 (1.19-2.12) with early diagnosis and glyburide treatment and 1.53 (1.15-2.04) with early diagnosis and dietary treatment.
conclusionsChildren exposed to GDM diagnosed before the standard time frame of 24 weeks, regardless of treatment type, meeting of glycemic targets, or maternal prepregnancy BMI, are more likely to develop obesity up to 11 years later.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.